ISPOR Announces New Summit on Value Assessment

Published Jun 26, 2018

Summit Scheduled for October 19, 2018 in Washington, DC, USA

Lawrenceville, NJ, USA—June 26, 2018—ISPOR, the professional society for health economics and outcomes research, announced a new ISPOR Summit “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare” scheduled for October 19, 2018 in Washington, DC, USA. As healthcare pricing (particularly drug pricing) faces greater scrutiny and healthcare costs continue to increase year after year, this Summit will examine various approaches to measuring value and explore how these value assessments could be used in pricing and coverage decisions. Because the definition of “value” often varies depending upon one’s perspective and decision context, the Summit will consider viewpoints from a variety of healthcare stakeholders, including patients, providers, payers, manufacturers, and others. Speakers will discuss how “value” should be defined and assessed, especially when considerations of fostering innovation are taken into account in the value equation. This Summit will complement the recently published work by the ISPOR Special Task Force for the Initiative on US Value Assessment Frameworks by creating a forum for discussion of the research agenda and current initiatives. By convening a broad range of stakeholders, the Summit will focus on how pricing could better reflect the value that patients and society as a whole derive from healthcare. Registration and additional information on the Summit can be found here.

###

ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×